Compare MTX & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MTX | LMAT |
|---|---|---|
| Founded | 1968 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.6B |
| IPO Year | 2004 | 2006 |
| Metric | MTX | LMAT |
|---|---|---|
| Price | $72.87 | $117.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | $81.33 | ★ $105.80 |
| AVG Volume (30 Days) | 163.9K | ★ 201.1K |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | 0.66% | ★ 0.87% |
| EPS Growth | N/A | ★ 30.57 |
| EPS | N/A | ★ 2.52 |
| Revenue | ★ $2,072,600,000.00 | $249,602,000.00 |
| Revenue This Year | $5.66 | $14.21 |
| Revenue Next Year | $4.47 | $8.88 |
| P/E Ratio | ★ N/A | $45.66 |
| Revenue Growth | N/A | ★ 13.53 |
| 52 Week Low | $49.54 | $78.01 |
| 52 Week High | $75.30 | $115.33 |
| Indicator | MTX | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 61.44 | 71.99 |
| Support Level | $64.99 | $81.60 |
| Resistance Level | $75.30 | N/A |
| Average True Range (ATR) | 1.65 | 3.08 |
| MACD | 0.44 | 0.30 |
| Stochastic Oscillator | 85.97 | 97.87 |
Minerals Technologies Inc mines, produces, and sells mineral-based products. The firm organizes itself into two segments: The Consumer & Specialties segment that derives maximum revenue, serves consumer end markets directly with mineral-to-market finished products and also provides specialty mineral-based solutions and technologies that are an essential component of its customers' finished products; and The Engineered Solutions segment serves industrial end markets with engineered systems, mineral blends, and technologies that are designed to improve its customers' manufacturing processes and projects. The majority of revenue comes from the United States, while it also has its presence in Canada/Latin America, Europe/Africa, and Asia.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.